Weekly CSR Email Newsletter
Distribute Press Releases To Chinese Media!Getting your company's message to journalists is important in China and ChinaNewswire.com can assist you in English-language releases and Xinwengao.com can provide Chinese-language distribution services. Corporate press releases are the most cost-effective way for you to connect with your customers and stakeholders in China!
• Global CSR Summit 2009 @ Singapore - 2009/01/13
• 2nd Annual Anti-Corruption Asia Congress @ Hong Kong - 2009/01/19
• Outsourcing Asia Summit 2009 @ Singapore - 2009/02/18
• Anti-Monopoly & Competition Law Asia Forum @ Hong Kong - 2009/02/24
• Ultra High-rise Buildings Summit @ Shanghai - 2009/03/26
• Export Control and Trade Compliance Asia Summit @ Beijing - 2009/04/21
Let us work with you in China to manage your email marketing campaigns, loyalty marketing programs, email newsletters, and digital marketing efforts while we improve your email deliverability in China. Our software and staff can help your company stay #1! Visit XZList.com
Sinovac Biotech Begins H5N1 Vaccine Clinical Trials In Beijing
December 22, 2005 |
Print
| 
Email
| Category: News
Sinovac Biotech has initiated human clinical trials for its pandemic flu (H5N1) vaccine Panflu(TM). The vaccine was administered to the first 6 volunteers at the Beijing Sino-Japan Friendship Hospital in Beijing.
Due to this vaccine's mature technology, China's State Food and Drug Administration (SFDA) earlier approved modification to "fast-track" the clinical trial process from 3 phases to only 2 stages.
Stage I includes 120 healthy volunteers, ages 18 - 60 years and is expected to take nine-months. However, preliminary results should be available by the end of March, 2006.
Sinovac partnered with Beijing Sino-Japan Friendship Hospital for the successful Phase I SARS clinical trials in 2004.
Protocols for clinical trials are strictly regulated and include compliance with SFDA's National Institute for the Control of Pharmaceutical and Biological Products (NICPBP), World Health Organization (WHO) "Guidelines on Clinical Evaluation of Vaccines," and other relevant regulations.
The trials will be compliant with Good Clinical Practices (GCP) procedures, including ethical guidelines.
Rate this page: 
Loading ...Leave A Comment:
-
Business & Society
-
Consumer
-
Education
- CUG Offers One-stop Service For Students
- China To Provide Scholarships For SUNY Undergraduates
- China To Help Pay Tuition Fee And Loans For College Graduates Going West
- ME Invests CNY4.4 Billion To Speed Up Education In Middle And West China
- Johnson Controls Works With SIFE China To Help Build Future Business Leaders
-
Happenings
-
Health
-
Labor
- Staff Claim Compensation From Sony Ericsson In Beijing
- Macau Companies Rush To Sign Labor Contracts With Employees
- Multinational Companies Must Not Delay Establishment Of Trade Unions In China
- China Will Give High Priority To College Graduates' Employment
- Manufacturer Wins Right To Dismiss Trade Union Chief In China
-
Law & Order
-
Viewpoints
- Global Financial Woes May Impact Corporate Social Responsibility In China
- Harmonious Corporate Social Responsibility In China: More Prophesy Than Reality?
- Year Of The Rat Brings A Plague Upon Employers In China
- Incorporating Healthcare Into CSR Programs
- MBA Toolkit For CSR: Government Relations And Public Affairs
Copyright 2003-2009 ChinaCSR.com. All Rights Reserved.
ChinaCSR.com is a service of BDL Media Ltd. If you would like to syndicate these articles and posts, please utilize the RSS feed for this online publication, which provides a brief summary of each post with a link back to the original article. Posting of any other part of the articles or posts on this website, in whole or in part, is expressly prohibited without express written permission from BDL Media.
